Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Managed Health Care - NEC
- Sub-Industry: Managed Health Care
- Symbol: NYSE:HUM
- CUSIP: 44485910
- Web: www.humana.com
Capitalization:- Market Cap: $33.90101 billion
- Outstanding Shares: 144,314,000
Average Prices:- 50 Day Moving Avg: $235.96
- 200 Day Moving Avg: $219.37
- 52 Week Range: $163.50 - $243.74
P/E:- Trailing P/E Ratio: 23.80
- Foreward P/E Ratio: 19.33
- P/E Growth: 1.63
Sales & Book Value:- Annual Revenue: $54.34 billion
- Price / Sales: 0.62
- Book Value: $70.91 per share
- Price / Book: 3.29
Dividend:- Annual Dividend: $1.60
- Dividend Yield: 0.7%
Profitability:- EBIDTA: $2.27 billion
- Net Margins: 2.71%
- Return on Equity: 14.38%
- Return on Assets: 5.44%
Debt:- Debt-to-Equity Ratio: 0.47%
- Current Ratio: 1.65%
- Quick Ratio: 1.65%
Misc:- Average Volume: 1.45 million shs.
- Beta: 0.91
- Short Ratio: 3.51
Frequently Asked Questions for Humana (NYSE:HUM)
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana declared a quarterly dividend on Thursday, April 20th. Shareholders of record on Friday, June 30th will be given a dividend of $0.40 per share on Monday, July 31st. This represents a $1.60 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Wednesday, June 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana announced that its board has authorized a share buyback plan on Tuesday, April 11th 2017, which permits the company to repurchase $2,250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 7.3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc. (NYSE:HUM) issued its quarterly earnings data on Wednesday, May, 3rd. The company reported $2.75 EPS for the quarter, topping the consensus estimate of $2.55 by $0.20. The firm earned $13.76 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 14.38% and a net margin of 2.71%. During the same quarter in the previous year, the company earned $1.86 EPS. View Humana's Earnings History.
When will Humana make its next earnings announcement?
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $11.10+ for the period, compared to the Thomson Reuters consensus estimate of $11.15.
Where is Humana's stock going? Where will Humana's stock price be in 2017?
19 brokerages have issued 1-year target prices for Humana's stock. Their predictions range from $200.00 to $275.00. On average, they anticipate Humana's share price to reach $234.89 in the next year. View Analyst Ratings for Humana.
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Kurt J. Hilzinger, Independent Chairman of the Board
- Bruce D. Broussard, President, Chief Executive Officer, Director
- Brian A. Kane, Chief Financial Officer, Senior Vice President
- Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
- Brian P. LeClaire, Senior Vice President, Chief Information Officer
- Sam Deshpande, Senior Vice President, Chief Risk Officer
- Christopher M. Todoroff, Senior Vice President, General Counsel
- Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
- Jody L. Bilney, Senior Vice President, Chief Consumer Officer
- Christopher H. Hunter, Senior Vice President, Chief Strategy Officer
Who owns Humana stock?
Humana's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.37%), Acadian Asset Management LLC (0.29%), Bank of Montreal Can (0.26%), APG Asset Management N.V. (0.17%), National Pension Service (0.09%) and Chevy Chase Trust Holdings Inc. (0.09%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Institutional Ownership Trends for Humana.
Who sold Humana stock? Who is selling Humana stock?
Humana's stock was sold by a variety of institutional investors in the last quarter, including Boston Advisors LLC, Exxonmobil Investment Management Inc. TX, Chevy Chase Trust Holdings Inc., NN Investment Partners Holdings N.V., Hartford Investment Management Co., First Citizens Bank & Trust Co., Strs Ohio and State Treasurer State of Michigan. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Insider Buying and Selling for Humana.
Who bought Humana stock? Who is buying Humana stock?
Humana's stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Russell Investments Group Ltd., Bank of Montreal Can, APG Asset Management N.V., CHURCHILL MANAGEMENT Corp, Meeder Asset Management Inc., Aperio Group LLC and Mn Services Vermogensbeheer B.V.. View Insider Buying and Selling for Humana.
How do I buy Humana stock?
Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of Humana stock can currently be purchased for approximately $233.50.
MarketBeat Community Rating for Humana (NYSE HUM)MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 7 Hold Ratings, 12 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.63) |
| Consensus Price Target: | $234.89 (0.59% upside) |
Analysts' Ratings History for Humana (NYSE:HUM)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/14/2017 | Piper Jaffray Companies | Reiterated Rating | Buy | $246.00 | Low |  |
| 7/14/2017 | Cowen and Company | Reiterated Rating | Buy | $230.00 | Low | |
| 7/14/2017 | Bank of America Corporation | Boost Price Target | Buy | $270.00 -> $275.00 | Low | |
| 7/13/2017 | Credit Suisse Group | Reiterated Rating | Outperform | $245.00 -> $250.00 | Low | |
| 6/28/2017 | Citigroup Inc. | Initiated Coverage | Buy -> Buy | $275.00 | Medium | |
| 6/23/2017 | Cantor Fitzgerald | Reiterated Rating | Not Available -> Neutral | | Low | |
| 6/9/2017 | Argus | Upgrade | Hold -> Buy | $260.00 | Low | |
| 6/6/2017 | Morgan Stanley | Initiated Coverage | Overweight -> Overweight | $262.00 | Low | |
| 6/5/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $214.00 | Low | |
| 5/30/2017 | Leerink Swann | Boost Price Target | Outperform | $250.00 -> $265.00 | Low | |
| 5/10/2017 | Deutsche Bank AG | Lower Price Target | Hold | $234.00 -> $216.00 | Low | |
| 5/4/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $221.00 -> $230.00 | High | |
| 4/25/2017 | Evercore ISI | Reiterated Rating | Outperform | $240.00 | Low | |
| 3/30/2017 | CIBC | Reiterated Rating | Outperform | | Low | |
| 3/30/2017 | Oppenheimer Holdings, Inc. | Initiated Coverage | Outperform -> Outperform | $236.00 -> $236.00 | Low | |
| 1/24/2017 | Stifel Nicolaus | Downgrade | Buy -> Hold | $214.00 -> $210.00 | N/A | |
| 1/9/2017 | Barclays PLC | Reiterated Rating | Hold | $217.00 | N/A | |
| 12/4/2016 | Susquehanna Bancshares Inc | Reiterated Rating | Neutral | $180.00 -> $200.00 | N/A | |
| 11/10/2016 | J P Morgan Chase & Co | Upgrade | Neutral -> Overweight | $163.00 -> $202.00 | N/A | |
| 7/22/2016 | FBR & Co | Lower Price Target | Mkt Perform | $220.00 -> $170.00 | N/A | |
| 7/21/2016 | Wolfe Research | Upgrade | Outperform | $192.00 | N/A | |
(Data available from 7/27/2015 forward)
Earnings History for Humana (NYSE:HUM)Earnings History by Quarter for Humana (NYSE HUM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/2/2017 | | $3.08 | | | | | N/A | |
| 5/3/2017 | Q1 2017 | $2.55 | $2.75 | $13.61 billion | $13.76 billion | View | N/A | |
| 2/8/2017 | Q416 | $2.05 | $2.09 | $13.55 billion | $12.88 billion | View | N/A | |
| 11/4/2016 | Q316 | $3.09 | $3.18 | $13.41 billion | $13.69 billion | View | N/A | |
| 8/3/2016 | Q216 | $2.23 | $2.30 | $13.59 billion | $14.00 billion | View | N/A | |
| 5/4/2016 | Q1 | $1.81 | $1.86 | $13.80 billion | $13.80 billion | View | N/A | |
| 2/10/2016 | Q415 | $1.45 | $1.45 | $13.51 billion | $13.40 million | View | N/A | |
| 11/6/2015 | Q315 | $2.13 | $2.16 | $13.64 billion | $13.36 billion | View | N/A | |
| 7/29/2015 | Q215 | $1.63 | $1.67 | $13.81 billion | $13.73 billion | View | N/A | |
| 4/29/2015 | Q115 | $2.54 | $2.47 | $13.51 billion | $13.80 billion | View | Listen | |
| 2/4/2015 | Q414 | $1.16 | $1.09 | $12.41 billion | $12.23 million | View | Listen | |
| 11/7/2014 | Q314 | $2.01 | $1.85 | $12.34 billion | $12.24 billion | View | Listen | |
| 7/30/2014 | Q214 | $2.19 | $2.19 | $11.93 billion | $12.22 billion | View | Listen | |
| 5/7/2014 | Q114 | $1.94 | $2.35 | $11.45 billion | $11.71 billion | View | Listen | |
| 2/5/2014 | Q413 | $0.95 | ($0.19) | $10.23 billion | $10.20 billion | View | Listen | |
| 11/6/2013 | Q313 | $2.14 | $2.31 | $10.27 billion | $10.00 billion | View | Listen | |
| 7/31/2013 | Q2 2013 | $2.46 | $2.63 | $10.36 billion | $10.32 billion | View | Listen | |
| 5/1/2013 | Q1 2013 | $1.80 | $2.95 | $10.23 billion | $10.49 billion | View | Listen | |
| 2/4/2013 | Q4 2012 | $1.07 | $1.19 | $9.73 billion | $9.56 billion | View | Listen | |
| 11/5/2012 | Q312 | $2.05 | $2.62 | $9.86 billion | $9.65 billion | View | N/A | |
| 7/30/2012 | | $2.21 | $2.16 | | | View | N/A | |
| 4/30/2012 | | $1.54 | $1.49 | | | View | N/A | |
| 2/6/2012 | | $1.20 | $1.20 | | | View | N/A | |
| 10/31/2011 | | $2.03 | $2.54 | | | View | N/A | |
| 8/1/2011 | | $2.05 | $2.50 | | | View | N/A | |
| 5/2/2011 | | $1.86 | $1.86 | | | View | N/A | |
| 2/7/2011 | | $0.81 | $0.63 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Humana (NYSE:HUM)2017 EPS Consensus Estimate: $10.69
2018 EPS Consensus Estimate: $13.58
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 4 | $2.07 | $2.75 | $2.36 |
| Q2 2017 | 4 | $2.37 | $3.29 | $3.00 |
| Q3 2017 | 4 | $3.15 | $3.44 | $3.26 |
| Q4 2017 | 4 | $1.77 | $2.56 | $2.08 |
| Q1 2018 | 1 | $2.95 | $2.95 | $2.95 |
| Q2 2018 | 1 | $3.41 | $3.41 | $3.41 |
| Q3 2018 | 1 | $3.61 | $3.61 | $3.61 |
| Q4 2018 | 1 | $3.61 | $3.61 | $3.61 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Humana (NYSE:HUM)| Next Dividend: | 7/31/2017 |
| Annual Dividend: | $1.60 |
| Dividend Yield: | 0.69% |
| Dividend Growth: | 3.10% (3 Year Average) |
| Payout Ratio: | 16.24% (Trailing 12 Months of Earnings)
14.41% (Based on This Year's Estimates)
13.25% (Based on Next Year's Estimates)
|
| Track Record: | 6 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Humana (NYSE HUM)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/20/2017 | quarterly | $0.40 | 0.75% | 6/28/2017 | 6/30/2017 | 7/31/2017 |
| 2/15/2017 | quarterly | $0.40 | 0.78% | 3/29/2017 | 3/31/2017 | 4/28/2017 |
| 10/26/2016 | quarterly | $0.29 | 0.67% | 1/10/2017 | 1/12/2017 | 1/27/2017 |
| 8/25/2016 | quarterly | $0.29 | 0.65% | 10/11/2016 | 10/13/2016 | 10/28/2016 |
| 4/21/2016 | quarterly | $0.29 | 0.66% | 6/28/2016 | 6/30/2016 | 7/29/2016 |
| 2/18/2016 | quarterly | $0.29 | 0.7% | 3/29/2016 | 3/31/2016 | 4/29/2016 |
| 10/29/2015 | quarterly | $0.29 | 0.65% | 12/28/2015 | 12/30/2015 | 1/29/2016 |
| 8/27/2015 | quarterly | $0.29 | 0.63% | 9/28/2015 | 9/30/2015 | 10/30/2015 |
| 4/17/2015 | quarterly | $0.29 | 0.65% | 6/26/2015 | 6/30/2015 | 7/31/2015 |
| 2/18/2015 | quarterly | $0.28 | 0.73% | 3/27/2015 | 3/31/2015 | 4/24/2015 |
| 10/31/2014 | quarterly | $0.28 | 0.81% | 12/29/2014 | 12/31/2014 | 1/30/2015 |
| 8/27/2014 | quarterly | $0.28 | 0.88% | 9/26/2014 | 9/30/2014 | 10/31/2014 |
| 4/30/2014 | quarterly | $0.28 | 1.02% | 6/26/2014 | 6/30/2014 | 7/25/2014 |
| 2/19/2014 | quarterly | $0.27 | 1.06% | 3/27/2014 | 3/31/2014 | 4/25/2014 |
| 10/30/2013 | quarterly | $0.27 | 1.17% | 12/27/2013 | 12/31/2013 | 1/31/2014 |
| 8/22/2013 | quarterly | $0.27 | 1.14% | 9/26/2013 | 9/30/2013 | 10/25/2013 |
| 4/25/2013 | quarterly | $0.27 | 1.47% | 6/26/2013 | 6/28/2013 | 7/26/2013 |
| 2/27/2013 | quarterly | $0.26 | 1.52% | 3/26/2013 | 3/28/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 99.08%
Insider Trades by Quarter for Humana (NYSE:HUM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/28/2017 | Brian P Leclaire | SVP | Sell | 4,971 | $240.00 | $1,193,040.00 | |
| 5/26/2017 | Heidi S Margulis | VP | Sell | 1,500 | $231.96 | $347,940.00 | |
| 5/5/2017 | Jody L Bilney | SVP | Sell | 4,600 | $230.16 | $1,058,736.00 | |
| 5/4/2017 | Bruce D Broussard | CEO | Sell | 118,231 | $225.82 | $26,698,924.42 | |
| 5/4/2017 | Timothy S Huval | VP | Sell | 13,939 | $225.86 | $3,148,262.54 | |
| 3/21/2017 | Jody L Bilney | SVP | Sell | 4,348 | $213.80 | $929,602.40 | |
| 3/6/2017 | James E Murray | COO | Sell | 31,151 | $213.62 | $6,654,476.62 | |
| 3/3/2017 | Cynthia H Zipperle | VP | Sell | 1,885 | $213.37 | $402,202.45 | |
| 2/24/2017 | Brian P Leclaire | SVP | Sell | 4,971 | $204.81 | $1,018,110.51 | |
| 2/22/2017 | Brian P Leclaire | SVP | Sell | 26,894 | $205.24 | $5,519,724.56 | |
| 2/22/2017 | James E Murray | COO | Sell | 9,523 | $204.69 | $1,949,262.87 | |
| 2/22/2017 | Roy A Beveridge | VP | Sell | 4,832 | $205.73 | $994,087.36 | |
| 2/21/2017 | Bruce D Broussard | CEO | Sell | 104,256 | $205.23 | $21,396,458.88 | |
| 2/21/2017 | Cynthia H Zipperle | CAO | Sell | 4,213 | $204.67 | $862,274.71 | |
| 2/21/2017 | David A. Jr/Ky Jones | Director | Sell | 27,000 | $205.04 | $5,536,080.00 | |
| 2/21/2017 | James E Murray | COO | Sell | 70,332 | $205.20 | $14,432,126.40 | |
| 2/21/2017 | Jody L Bilney | SVP | Sell | 6,087 | $204.72 | $1,246,130.64 | |
| 2/21/2017 | M Todoroff Christopher | VP | Sell | 24,140 | $205.33 | $4,956,666.20 | |
| 2/25/2016 | Brian P Leclaire | SVP | Sell | 183 | $176.11 | $32,228.13 | |
| 3/11/2015 | James E Murray | COO | Sell | 35,220 | $160.90 | $5,666,898.00 | |
| 3/2/2015 | Brian P Leclaire | SVP | Sell | 5,500 | $161.79 | $889,845.00 | |
| 2/25/2015 | Bruce D Broussard | CEO | Sell | 41,105 | $165.29 | $6,794,245.45 | |
| 2/25/2015 | David A Jr/Ky Jones | Director | Sell | 6,100 | $165.39 | $1,008,879.00 | |
| 2/24/2015 | Heidi S Margulis | VP | Sell | 3,665 | $164.44 | $602,672.60 | |
| 8/22/2014 | Brian P Leclaire | SVP | Sell | 3,250 | $123.04 | $399,880.00 | |
| 5/15/2014 | Heidi Margulis | VP | Sell | 3,345 | $119.56 | $399,928.20 | |
| 5/12/2014 | Marissa Peterson | Director | Sell | 2,026 | $123.30 | $249,805.80 | |
| 3/19/2014 | James Murray | COO | Sell | 36,833 | $116.59 | $4,294,359.47 | |
| 3/18/2014 | M Todoroff Christopher | VP | Sell | 8,000 | $113.20 | $905,600.00 | |
| 3/13/2014 | Bruce Broussard | CEO | Sell | 109,000 | $109.84 | $11,972,560.00 | |
| 3/10/2014 | Webster Roy Dunbar | Director | Sell | 9,587 | $110.30 | $1,057,446.10 | |
| 12/4/2013 | Marissa Peterson | Director | Sell | 1,147 | $103.54 | $118,760.38 | |
| 12/2/2013 | M Todoroff Christopher | VP | Sell | 6,000 | $105.50 | $633,000.00 | |
| 11/26/2013 | Heidi Margulis | VP | Sell | 5,500 | $104.42 | $574,310.00 | |
| 11/8/2013 | David Jr/Ky Jones | Director | Sell | 11,000 | $95.00 | $1,045,000.00 | |
| 9/5/2013 | Elizabeth D Bierbower | Insider | Sell | 17,673 | $96.01 | $1,696,784.73 | |
| 8/30/2013 | Heidi Margulis | VP | Sell | 3,319 | $93.35 | $309,828.65 | |
| 8/29/2013 | David Jr/Ky Jones | Director | Sell | 2,500 | $93.01 | $232,525.00 | |
| 8/23/2013 | Elizabeth Bierbower | Insider | Sell | 6,063 | $94.00 | $569,922.00 | |
| 8/15/2013 | Michael Mccallister | Director | Sell | 138,817 | $91.49 | $12,700,367.33 | |
| 8/13/2013 | Bruce Perkins | Insider | Sell | 9,000 | $93.47 | $841,230.00 | |
| 8/8/2013 | Steven Mcculley | VP | Sell | 10,000 | $92.54 | $925,400.00 | |
| 8/7/2013 | James Bloem | CFO | Sell | 33,000 | $91.79 | $3,029,070.00 | |
| 8/1/2013 | M Todoroff Christopher | VP | Sell | 39,596 | $90.30 | $3,575,518.80 | |
| 6/24/2013 | Paul B K Kusserow | SVP | Sell | 34,219 | $84.60 | $2,894,927.40 | |
| 6/18/2013 | Elizabeth D Bierbower | Insider | Sell | 8,033 | $83.29 | $669,068.57 | |
| 5/30/2013 | James E Murray | COO | Sell | 11,000 | $81.96 | $901,560.00 | |
| 5/9/2013 | Michael B Mccallister | Director | Sell | 281,312 | $77.72 | $21,863,568.64 | |
(Data available from 1/1/2013 forward)
Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
| Source: |
|
| Date | Headline |
|---|
 | Humana Inc. (NYSE:HUM) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - July 27 at 11:51 AM |
 | Health care CEO take-home pay has flourished under ACA - Louisville Business First
www.bizjournals.com - July 26 at 4:01 PM |
 | Health care CEO take-home pay has flourished under ACA
finance.yahoo.com - July 26 at 4:01 PM |
 | YieldBoost HUM To 3.6% Using Options
www.nasdaq.com - July 25 at 7:57 PM |
| Humana has billions in cash on hand — did Obamacare really hurt that much?
www.bizjournals.com - July 25 at 7:57 PM |
| Comparing Humana (NYSE:HUM) and UnitedHealth Group (UNH)
www.americanbankingnews.com - July 24 at 8:22 PM |
| Humana Inc. (NYSE:HUM) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - July 23 at 4:58 PM |
| Quotient Investors, LLC Buys Norfolk Southern Corp, Humana Inc, Assurant Inc, Sells Brookdale ... - Nasdaq
www.nasdaq.com - July 22 at 8:08 PM |
| CBO's Secret: 73% Of Coverage Difference Between Obamacare & GOP Bills Driven By Individual Mandate
finance.yahoo.com - July 22 at 8:08 PM |
| Humana hiring hundreds in Louisville for Medicare Advantage enrollments
www.bizjournals.com - July 20 at 11:13 PM |
| GOP Obamacare retreat will hit insurers on the tax front
finance.yahoo.com - July 18 at 9:57 PM |
| Humana Inc. (NYSE:HUM) Price Target Increased to $275.00 by Analysts at Bank of America Corporation
www.americanbankingnews.com - July 15 at 7:52 PM |
| Humana Inc. (HUM) Receives "Buy" Rating from Piper Jaffray Companies
www.americanbankingnews.com - July 15 at 10:16 AM |
| Humana's (HUM) Buy Rating Reiterated at Cowen and Company
www.americanbankingnews.com - July 15 at 8:14 AM |
| Humana Inc. (HUM) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 14 at 11:32 AM |
| Humana Inc. (NYSE:HUM) Stock Rating Reaffirmed by Credit Suisse Group
www.americanbankingnews.com - July 13 at 8:13 AM |
 | Humana and Oscar Health Enter Strategic Partnership to Offer ... - Business Wire (press release)
www.businesswire.com - July 13 at 2:53 AM |
| Humana and Oscar Health Enter Strategic Partnership to Offer Consumer-Focused, Technology-Driven Commercial Small Business Health Insurance, Beginning in Nashville Area
finance.yahoo.com - July 13 at 2:52 AM |
| Humana And Oscar Partner To Sell Health Plans To Small Businesses
finance.yahoo.com - July 13 at 2:52 AM |
| $13.64 Billion in Sales Expected for Humana Inc. (NYSE:HUM) This Quarter
www.americanbankingnews.com - July 12 at 9:14 AM |
 | Oscar Health to join Humana in a small business venture
www.cnbc.com - July 12 at 7:53 AM |
 | Humana and Oscar Health inks deal to offer commercial small business health insurance, beginning in Nashville area
seekingalpha.com - July 12 at 7:34 AM |
| Humana Inc. to Release Second Quarter 2017 Results on August 2, 2017 - Business Wire (press release)
www.businesswire.com - July 11 at 5:40 AM |
| $3.05 Earnings Per Share Expected for Humana Inc. (HUM) This Quarter
www.americanbankingnews.com - July 11 at 12:20 AM |
| Humana Inc. to Release Second Quarter 2017 Results on August 2, 2017
finance.yahoo.com - July 10 at 7:36 PM |
| Humana hikes pay for board of directors
finance.yahoo.com - July 7 at 6:16 AM |
| Study of Managed Care Population Suggests Inferior Vena Cava Filters May Be Overused
finance.yahoo.com - July 7 at 6:16 AM |
| Humana exec sells $4 million in company stock
finance.yahoo.com - July 5 at 8:17 PM |
| Humana Inc. (HUM) Earns Buy Rating from Analysts at Citigroup Inc.
www.americanbankingnews.com - July 2 at 8:08 PM |
| Humana subsidiary will expand into KC with 4 primary-care clinics
www.bizjournals.com - June 30 at 7:44 PM |
| UPDATE 2-Aetna settles on New York for new headquarters in 2018
finance.yahoo.com - June 30 at 7:44 PM |
| [$$] Insurers’ Policy Warnings Raise Stakes in Health Fight
finance.yahoo.com - June 30 at 7:44 PM |
 | Aetna settles on New York for new headquarters in 2018 - Reuters
www.reuters.com - June 30 at 4:58 AM |
| Technical Reports on Healthcare Equities -- UnitedHealth, Humana, Molina Healthcare, and Quorum Health
www.bizjournals.com - June 29 at 11:58 PM |
| Analyzing WellCare Health Plans (WCG) and Humana (HUM)
www.americanbankingnews.com - June 29 at 8:34 PM |
| Humana Inc. (HUM) SVP Sells $1,193,040.00 in Stock
www.americanbankingnews.com - June 29 at 4:28 PM |
 | Anthem's Exit Creates Obamacare `Crisis' for Rural Nevadans - Bloomberg
www.bloomberg.com - June 29 at 5:15 AM |
| Humana Foundation Awards $640000 to Knoxville Nonprofits to Improve Health of Community - Business Wire (press release)
www.businesswire.com - June 29 at 12:14 AM |
| Humana Foundation Awards $640,000 to Knoxville Nonprofits to Improve Health of Community
finance.yahoo.com - June 28 at 7:12 PM |
| Don't Expect Failed Humana Deal To Quash Aetna's Desire For M&A
finance.yahoo.com - June 28 at 7:12 PM |
| Humana Inc. (HUM) Forecasted to Earn FY2018 Earnings of $11.50 Per Share
www.americanbankingnews.com - June 26 at 9:18 AM |
| Humana out of individual market, with or without Obamacare repeal - Reuters
www.reuters.com - June 24 at 6:08 PM |
| Humana has a new position — and a new person — in its C-suite
www.bizjournals.com - June 23 at 11:05 PM |
| CEO Broussard says Humana is out of the individual market, no matter what happens with Obamacare
www.bizjournals.com - June 23 at 6:03 PM |
| Humana Names Sam Deshpande Chief Risk Officer
finance.yahoo.com - June 23 at 6:03 PM |
| Here's What to Watch as the Senate Fights Over Healthcare Reform
finance.yahoo.com - June 23 at 6:03 PM |
| Federal Trade Commission files petition to get court to enforce ... - Memphis Business Journal
www.bizjournals.com - June 22 at 6:25 PM |
| Humana out of individual market, with or without Obamacare repeal
www.cnbc.com - June 22 at 1:23 PM |
| Legal update: FTC, Humana file motion re: Walgreens/Rite Aid investigation
www.bizjournals.com - June 22 at 1:23 PM |
| Humana Inc. (HUM) Upgraded at BidaskClub
www.americanbankingnews.com - June 21 at 6:20 PM |
Humana (HUM) Chart for Thursday, July, 27, 2017
